Esophagogastric Cancer: Enhancing Outcomes Through Biomarkers and Collaborative Care - Module 1
Update: 2025-08-07
Description
Esophagogastric Cancer: Enhancing Outcomes Through Biomarkers and Collaborative Care is an accredited, two-part series led by expert Yelena Y. Janjigian, MD.
In module 1, Dr. Janjigian provides an in-depth overview of the latest biomarkers—such as HER2, PD-L1, MMR/MSI-H, CLDN18.2, and FGFR2—and their role in guiding treatment decisions for esophagogastric cancer. Learn about current biomarker testing methods, interpretation of results, and how to integrate biomarker data into clinical practice to personalize therapy and improve patient outcomes. Listen now!
Click here to claim you CE credit for this activity: bit.ly/45u106o
Click here to continue listening to Module 2 of this series: bit.ly/3HtOziO
In module 1, Dr. Janjigian provides an in-depth overview of the latest biomarkers—such as HER2, PD-L1, MMR/MSI-H, CLDN18.2, and FGFR2—and their role in guiding treatment decisions for esophagogastric cancer. Learn about current biomarker testing methods, interpretation of results, and how to integrate biomarker data into clinical practice to personalize therapy and improve patient outcomes. Listen now!
Click here to claim you CE credit for this activity: bit.ly/45u106o
Click here to continue listening to Module 2 of this series: bit.ly/3HtOziO
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
